TradingKey

Más Datos de Medtronic PLC Compañía

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Información de la empresa

Símbolo de cotizaciónMDT

Nombre de la empresaMedtronic PLC

Fecha de salida a bolsaNov 21, 1977

Fundada en2014

Director ejecutivoMr. Geoffrey S. (Geoff) Martha

Número de empleados95000

Tipo de seguridadOrdinary Share

Fin del año fiscalNov 21

DirecciónBuilding Two Parkmore Business Park West

CiudadDUBLIN

Bolsa de valoresNYSE Consolidated

PaísIreland

Código postalH91 4K49

Teléfono1135314381700

Sitio Webhttps://www.medtronic.com/

Símbolo de cotizaciónMDT

Fecha de salida a bolsaNov 21, 1977

Fundada en2014

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.06M

+3.66%

Mr. Sean M. Salmon

Executive Vice President, President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

496.43K

+2.01%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

120.89K

+8.81%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit

48.79K

+25.09%

Mr. Kendall J. (Ken) Powell

Independent Director

47.95K

+4.05%

Mr. Craig Arnold

Lead Independent Director

40.16K

+4.88%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

39.45K

+28.29%

Mr. Scott C. Donnelly

Independent Director

21.52K

+9.50%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.06M

+3.66%

Mr. Sean M. Salmon

Executive Vice President, President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

496.43K

+2.01%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

120.89K

+8.81%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit

48.79K

+25.09%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Surgical & Endoscopy

6.50B

19.38%

Cardiac Rhythm & Heart Failure

6.39B

19.06%

Cranial & Spinal Technologies

4.97B

14.83%

Coronary & Peripheral Vascular

3.55B

10.60%

Specialty Therapies

2.94B

8.77%

Other

9.18B

27.37%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

17.17B

51.20%

Rest of World

16.25B

48.45%

Ireland

116.00M

0.35%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Surgical & Endoscopy

6.50B

19.38%

Cardiac Rhythm & Heart Failure

6.39B

19.06%

Cranial & Spinal Technologies

4.97B

14.83%

Coronary & Peripheral Vascular

3.55B

10.60%

Specialty Therapies

2.94B

8.77%

Other

9.18B

27.37%

Estadísticas de accionistas

Actualizado: sáb., 26 de jul

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

5.38%

State Street Global Advisors (US)

4.69%

Capital Research Global Investors

3.24%

JP Morgan Asset Management

2.18%

Other

74.79%

Accionistas

Proporción

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

5.38%

State Street Global Advisors (US)

4.69%

Capital Research Global Investors

3.24%

JP Morgan Asset Management

2.18%

Other

74.79%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

45.74%

Investment Advisor/Hedge Fund

29.28%

Research Firm

3.90%

Pension Fund

2.28%

Bank and Trust

2.02%

Hedge Fund

1.92%

Sovereign Wealth Fund

1.24%

Insurance Company

0.38%

Individual Investor

0.25%

Other

12.99%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

3747

1.12B

87.05%

-12.52M

2025Q1

3818

1.13B

88.15%

+2.18M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.32M

2023Q1

3738

1.14B

85.40%

-14.71M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

124.44M

9.71%

+807.51K

+0.65%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

68.93M

5.38%

+886.72K

+1.30%

Mar 31, 2025

State Street Global Advisors (US)

60.04M

4.69%

-392.70K

-0.65%

Mar 31, 2025

Capital Research Global Investors

41.57M

3.24%

+8.36M

+25.19%

Mar 31, 2025

JP Morgan Asset Management

27.99M

2.18%

+3.65M

+15.02%

Mar 31, 2025

Geode Capital Management, L.L.C.

27.92M

2.18%

+860.11K

+3.18%

Mar 31, 2025

MFS Investment Management

20.60M

1.61%

+1.37M

+7.14%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

14.57M

1.14%

-1.01M

-6.49%

Dec 31, 2024

DWS Investment GmbH

14.36M

1.12%

-297.37K

-2.03%

Mar 31, 2025

BlackRock Financial Management, Inc.

14.15M

1.1%

+923.56K

+6.99%

Mar 31, 2025

ETFs relacionados

Actualizado: dom., 6 de jul

Nombre

Proporción

Absolute Select Value ETF

5.31%

Polen Capital International Growth ETF

5.15%

Cullen Enhanced Equity Income ETF

4.57%

Madison Covered Call ETF

4.36%

iShares U.S. Medical Devices ETF

4.32%

USCF Dividend Income Fund

3.53%

First Trust Active Global Quality Income ETF

3.13%

NYLI Healthy Hearts ETF

3.07%

American Century Focused Large Cap Value ETF

3.03%

iShares Health Innovation Active ETF

2.86%

Absolute Select Value ETF

Proporción5.31%

Polen Capital International Growth ETF

Proporción5.15%

Cullen Enhanced Equity Income ETF

Proporción4.57%

Madison Covered Call ETF

Proporción4.36%

iShares U.S. Medical Devices ETF

Proporción4.32%

USCF Dividend Income Fund

Proporción3.53%

First Trust Active Global Quality Income ETF

Proporción3.13%

NYLI Healthy Hearts ETF

Proporción3.07%

American Century Focused Large Cap Value ETF

Proporción3.03%

iShares Health Innovation Active ETF

Proporción2.86%

Dividendos

Un total de 17.37B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Medtronic PLC

89.303USD

Medtronic PLC

89.303

Descripción general

Compañía

Finanzas